Skip to search formSkip to main contentSkip to account menu

ketanserinol

Known as: 2,4(1H,3H)-Quinazolinedione, 3-(2-(4-((4-fluorophenyl)hydroxymethyl)-1-piperidinyl)ethyl)-, 3-(2-(4-((4-fluorophenyl)hydroxymethyl)-1-piperidinyl)ethyl)-2,4-(1H,3H)quinazolinedione, reduced ketanserin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The aim of this prospective, observational study was to assess transplacental transmission of ketanserin, an antihypertensive… 
2003
2003
A sensitive and selective high-performance liquid chromatographic assay for the quantification of ketanserin and ketanserinol in… 
2000
2000
Ketanserin, a hypotensive drug with 5-HT2 receptor antagonism, when administered by topical infusion of a 0.25% w/v solution by… 
1990
1990
SummaryThe pharmacokinetics of ketanserin, a new serotonin S2 (5HT2) antagonist, were studied in 26 patients with cirrhosis… 
1988
1988
In hypertensive patients single doses of ketanserin 40 mg prolonged the corrected QT interval (QTc) for at least 8 hours, with a… 
1988
1988
Summary:Inhypertensive patients single doses ofketanserin 40mgprolonged thecorrected QT interval (QT)foratleast 8hours… 
1987
1987
1. The antihypertensive efficacy and tolerability of twice-daily treatment with the 5-hydroxytryptamine antagonist ketanserin… 
1987
1987
Ten healthy volunteers received a single 10 mg intravenous dose of the 5‐hydroxytryptamine‐2 serotonin antagonist ketanserin in…